Actium Group portfolio

Actium Group has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Website: actiuminvest.com.

Type: Investor.

Portfolio on Recent Funding: 1.

Deals, last 12 months: 1.

Capital in their rounds: $60M.

Latest deal: Oyster Therapeutics · Nov 10, 2026.

About this page

Its most recent investment on record is Oyster Therapeutics's $60M Series A round in November 2026, alongside Global Brain Corporation, 4BIO Capital, Eli Lilly and 5 others. That company is in Health and bio.

What Actium Group invests in

Health and bio · 1 · 100%

How Actium Group invests

Stage	Deals	Capital in rounds
Series A	1 100%	$60M

Actium Group portfolio companies

OOyster Therapeutics$60MSeries A · Nov 2026

Company	Round with Actium Group	Total raised	Latest raise
OOyster Therapeutics Health and bio	Nov 10, 2026 Series A · $60M	$60M	Nov 10, 2026 Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Actium Group. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Actium Group, which is a subset of its real portfolio. API: /api/v1/investors/actium-group (get a free API key). More: the most active VC firms and new venture capital funds.